News

Respiratory tract infections in children: prevention is better than cure

It appears that acute respiratory infections are responsible for the largest number of antibiotic prescriptions. Children are even more likely than adults to receive antibiotic prescription. It has been estimated… Read more

Back to school time! Respiratory infections are back too…

As days are getting shorter, colder, children are about to spend more time in crowded nurseries or classrooms… and are at higher risks of respiratory tract infections. Why? Spending more… Read more

Summer viruses on the radar

Viruses are often associated with acute respiratory infections, for example, in the summer, rhinoviruses are the most common causes of acute respiratory infections. A comprehensive review of epidemiology studies shows… Read more

What is the risk of respiratory bacterial infections in the summer?

Bacteria account for up to 25% of upper respiratory tract infections, they are also responsible for otitis. Their presence in summer should not be neglected, and certain bacteria have even… Read more

Risks of respiratory tract infections are not limited to wintertime!

Seasonality is a well-known phenomenon in public health. Climatic changes (temperature, humidity, precipitation) can affect the development and transmission of certain pathogens. They also influence life style and behaviors, which… Read more

Join the Boostic Boy movement!

Play while you wait….Discover Boostic Boy, a mobile game developped by Lallemand Pharma to help improve patients experience in the waiting room. Ready, Steady, Let’s play! https://lnkd.in/e2d2Ts6 and; https://lnkd.in/eEVtiJu.

Join Lallemand Pharma on LinkedIn!

Lallemand Pharma is pleased to launch its LinkedIn showcase page, a place where we will be sharing news and events about respiratory health with professionals from around the world.

Sharing European Experience of PMBL use in COPD management with Russian experts

On 21st October 2016, Prof. Mario Cazzola, from the Department of Systems Medicine University of Rome Tor Vergata, Italy, shared “The European experience of treatment and prevention of COPD exacerbations”… Read more

The role of PMBL in pediatric patients and allergies discussed with Georgian practitioners

Late September 2016, our partner in Georgia, GM Pharmaceuticals, hold a medical conference dedicated to bacterial lysates applications in Tbilissi. This event attracted around 200 practitioners, mainly GPs, pediatricians and… Read more

PMBL™ reduces hospitalization time

Massagno, Switzerland

Results of a multicentre, double-blind, randomised, controlled, phase IV study in Chronic Obstructive Pulmonary Disease(COPD) patients were recently published1: the AIACE study (Advanced Immunological Approach in COPD Exacerbation). The study,… Read more